Digitisation | February 25, 2025
Amgen opens new technology and innovation site in Hyderabad
Amgen India investment totals $200 million through 2025
Amgen India investment totals $200 million through 2025
A nationwide network of over 1,000 accredited clinical trial sites will be created to accelerate drug development timelines and enhance research credibility
Revenues up 13.1% year-over-year; Continued momentum driven by organic growth, strategic partnerships, and acquisitions
India's bio economy has experienced remarkable growth, skyrocketing from $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
The investment will empower RDHL to develop a virtual diagnostic and care platform, expanding access to healthcare for underserved communities
Several crucial provisions to elevate the standards of nursing education and services, enhance professional conduct, and ensure greater transparency and accountability introduced
Acquisition will further strengthen Lonza’s bioconjugates offering through the integration of the industry-leading proprietary Synaffix technology platform and R&D capabilities, including payload and site-specific linker technology
Technology and innovation play a pivotal role towards enhancing healthcare systems, increasing access to healthcare services, and reducing costs of therapies and consultations
The company's long-term strategy is on science, technology and innovation and the company's strategy relating to this is on track
The policy aspires to reduce cost of logistics in India to be comparable to global benchmarks by 2030
Subscribe To Our Newsletter & Stay Updated
